Pharmaceuticals: Global Industry Guide

Publication Date	February 2008
Publisher	Datamonitor
Product Type	Report
Pages	243
ISBN Number	not applicable
Product Code	DAT04646

Price

£750.00
approximately: $1,324 | €951

PDF

PRINT £800 ($1,413 | €1,014)

Order above formats by FAX

Summary

Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

Contains an executive summary and data on value, volume and segmentation
Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
Incorporates in-depth five forces competitive environment analysis and scorecards
Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market grew by 5.5% in 2007 to reach a value of $577.2 billion.

In 2012, the market is forecast to have a value of $737.9 billion, an increase of 27.8% since 2007.

Sales of cardiovascular therapies account for 19.5% of the market by value.

The Americas is the largest pharmaceuticals market, accounting for 55% of the global market's value.

Pfizer is the leading company in the market, holding an 8.1% market share by value.

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Content

Chapter 1 Introduction
- 1.1 What is this report about?
- 1.2 Who is the target reader?
- 1.3 How to use this report
- 1.4 Definitions
Chapter 2 Global Pharmaceuticals
- 2.1 Market Overview
- 2.2 Market Value
- 2.3 Market Segmentation I
- 2.4 Market Segmentation II
- 2.5 Market Share
- 2.6 Five Forces Analysis
- 2.7 Market Forecasts
Chapter 3 Pharmaceuticals in Canada
- 3.1 Market Overview
- 3.2 Market Value
- 3.3 Market Segmentation I
- 3.4 Market Segmentation II
- 3.5 Market Share
- 3.6 Five Forces Analysis
- 3.7 Market Forecasts
- 3.8 Macroeconomic Indicators
Chapter 4 Pharmaceuticals in The United States
- 4.1 Market Overview
- 4.2 Market Value
- 4.3 Market Segmentation I
- 4.4 Market Segmentation II
- 4.5 Market Share
- 4.6 Five Forces Analysis
- 4.7 Market Forecasts
- 4.8 Macroeconomic Indicators
Chapter 5 Pharmaceuticals in China
- 5.1 Market Overview
- 5.2 Market Value
- 5.3 Market Segmentation I
- 5.4 Market Segmentation II
- 5.5 Market Share
- 5.6 Five Forces Analysis
- 5.7 Market Forecasts
- 5.8 Macroeconomic Indicators
Chapter 6 Pharmaceuticals in Japan
- 6.1 Market Overview
- 6.2 Market Value
- 6.3 Market Segmentation I
- 6.4 Market Segmentation II
- 6.5 Market Share
- 6.6 Five Forces Analysis
- 6.7 Market Forecasts
- 6.8 Macroeconomic Indicators
Chapter 7 Pharmaceuticals in Belgium
- 7.1 Market Overview
- 7.2 Market Value
- 7.3 Market Segmentation I
- 7.4 Market Segmentation II
- 7.5 Market Share
- 7.6 Five Forces Analysis
- 7.7 Market Forecasts
- 7.8 Macroeconomic Indicators
Chapter 8 Pharmaceuticals in France
- 8.1 Market Overview
- 8.2 Market Value
- 8.3 Market Segmentation I
- 8.4 Market Segmentation II
- 8.5 Market Share
- 8.6 Five Forces Analysis
- 8.7 Market Forecasts
- 8.8 Macroeconomic Indicators
Chapter 9 Pharmaceuticals in Germany
- 9.1 Market Overview
- 9.2 Market Value
- 9.3 Market Segmentation I
- 9.4 Market Segmentation II
- 9.5 Market Share
- 9.6 Five Forces Analysis
- 9.7 Market Forecasts
- 9.8 Macroeconomic Indicators
Chapter 10 Pharmaceuticals in Italy
- 10.1 Market Overview
- 10.2 Market Value
- 10.3 Market Segmentation I
- 10.4 Market Segmentation II
- 10.5 Market Share
- 10.6 Five Forces Analysis
- 10.7 Market Forecasts
- 10.8 Macroeconomic Indicators
Chapter 11 Pharmaceuticals in The Netherlands
- 11.1 Market Overview
- 11.2 Market Value
- 11.3 Market Segmentation I
- 11.4 Market Segmentation II
- 11.5 Market Share
- 11.6 Five Forces Analysis
- 11.7 Market Forecasts
- 11.8 Macroeconomic Indicators
Chapter 12 Pharmaceuticals in Spain
- 12.1 Market Overview
- 12.2 Market Value
- 12.3 Market Segmentation I
- 12.4 Market Segmentation II
- 12.5 Market Share
- 12.6 Five Forces Analysis
- 12.7 Market Forecasts
- 12.8 Macroeconomic Indicators
Chapter 13 Pharmaceuticals in The United Kingdom
- 13.1 Market Overview
- 13.2 Market Value
- 13.3 Market Segmentation I
- 13.4 Market Segmentation II
- 13.5 Market Share
- 13.6 Five Forces Analysis
- 13.7 Market Forecasts
- 13.8 Macroeconomic Indicators
Chapter 14 Pharmaceuticals in Asia-Pacific
- 14.1 Market Overview
- 14.2 Market Value
- 14.3 Market Segmentation I
- 14.4 Market Segmentation II
- 14.5 Market Share
- 14.6 Five Forces Analysis
- 14.7 Market Forecasts
Chapter 15 Pharmaceuticals in Europe
- 15.1 Market Overview
- 15.2 Market Value
- 15.3 Market Segmentation I
- 15.4 Market Segmentation II
- 15.5 Market Share
- 15.6 Five Forces Analysis
- 15.7 Market Forecasts
- 15.8 Macroeconomic Indicators
Chapter 16 Company Profiles
- 16.1 Leading Companies
Chapter 17 Appendix
- 17.1 Data Research Methodology
- 17.2 Report writing team
List of Tables
- Table 1: Global Pharmaceuticals Market Value: $ million, 2003-2007
- Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 5: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 6: Canada Pharmaceuticals Market Value: $ million, 2003-2007
- Table 7: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 8: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 9: Canada Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 10: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 11: Canada Size of Population (million) , 2003-2007
- Table 12: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 13: Canada Inflation, 2003-2007
- Table 14: Canada Exchange Rate, 2003-2007
- Table 15: United States Pharmaceuticals Market Value: $ million, 2003-2007
- Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 19: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 20: United States Size of Population (million) , 2003-2007
- Table 21: United States GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 22: United States Inflation, 2003-2007
- Table 23: China Pharmaceuticals Market Value: $ million, 2003-2007
- Table 24: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 25: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 26: China Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 27: China Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 28: China Size of Population (million) , 2003-2007
- Table 29: China GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 30: China Inflation, 2003-2007
- Table 31: China Exchange Rate, 2003-2007
- Table 32: Japan Pharmaceuticals Market Value: $ million, 2003-2007
- Table 33: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 34: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 35: Japan Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 36: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 37: Japan Size of Population (million) , 2003-2007
- Table 38: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 39: Japan Exchange Rate, 2003-2007
- Table 40: Belgium Pharmaceuticals Market Value: $ million, 2003-2007
- Table 41: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 42: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 43: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 44: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 45: Belgium Size of Population (million) , 2003-2007
- Table 46: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 47: Belgium Inflation, 2003-2007
- Table 48: Belgium Exchange Rate, 2003-2007
- Table 49: France Pharmaceuticals Market Value: $ million, 2003-2007
- Table 50: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 51: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 52: France Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 53: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 54: France Size of Population (million) , 2003-2007
- Table 55: France GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 56: France Inflation, 2003-2007
- Table 57: France Exchange Rate, 2003-2007
- Table 58: Germany Pharmaceuticals Market Value: $ million, 2003-2007
- Table 59: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 60: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 61: Germany Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 62: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 63: Germany Size of Population (million) , 2003-2007
- Table 64: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 65: Germany Inflation, 2003-2007
- Table 66: Germany Exchange Rate, 2003-2007
- Table 67: Italy Pharmaceuticals Market Value: $ million, 2003-2007
- Table 68: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 69: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 70: Italy Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 71: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 72: Italy Size of Population (million) , 2003-2007
- Table 73: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 74: Italy Inflation, 2003-2007
- Table 75: Italy Exchange Rate, 2003
- Table 76: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007
- Table 77: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 78: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 79: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 80: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 81: Netherlands Size of Population (million) , 2003-2007
- Table 82: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 83: Netherlands Inflation, 2003-2007
- Table 84: Netherlands Exchange Rate, 2003-2007
- Table 85: Spain Pharmaceuticals Market Value: $ million, 2003-2007
- Table 86: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 87: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 88: Spain Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 89: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 90: Spain Size of Population (million) , 2003-2007
- Table 91: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 92: Spain Inflation, 2003-2007
- Table 93: Spain Exchange Rate, 2003-2007
- Table 94: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007
- Table 95: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 96: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 97: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 98: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 99: United Kingdom Size of Population (million) , 2003-2007
- Table 100: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007
- Table 101: United Kingdom Inflation, 2003-2007
- Table 102: United Kingdom Exchange Rate, 2003-2007
- Table 103: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007
- Table 104: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 105: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 106: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 107: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 108: Europe Pharmaceuticals Market Value: $ million, 2003-2007
- Table 109: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Table 110: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Table 111: Europe Pharmaceuticals Market Share: % Share, by Value, 2007
- Table 112: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Table 113: Europe Exchange Rate, 2003-2007
- Table 114: Key Facts: Pfizer Inc
- Table 115: Key Financials: Pfizer Inc
- Table 116: Key Facts: GlaxoSmithKline Plc
- Table 117: Key Financials: GlaxoSmithKline Plc
- Table 118: Key Facts: Johnson & Johnson
- Table 119: Key Financials: Johnson & Johnson
- Table 120: Key Facts: Merck & Co., Inc
- Table 121: Key Financials: Merck & Co., Inc
List of Figures
- Figure 1: Global Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 5: Forces Driving Competition in the Global Pharmaceuticals Market, 2007
- Figure 6: Drivers of Buyer Power in the Global Pharmaceuticals Market, 2007
- Figure 7: Drivers of Supplier Power in the Global Pharmaceuticals Market, 2007
- Figure 8: Factors Influencing the Likelihood of New Entrants in the Global Pharmaceuticals Market, 2007
- Figure 9: Factors Influencing the Threat of Substitutes in the Global Pharmaceuticals Market, 2007
- Figure 10: Drivers of Degree of Rivalry in the Global Pharmaceuticals Market, 2007
- Figure 11: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 12: Canada Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 13: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 14: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 15: Canada Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 16: Forces Driving Competition in the Pharmaceuticals Market in Canada, 2007
- Figure 17: Drivers of Buyer Power in the Pharmaceuticals Market in Canada, 2007
- Figure 18: Drivers of Supplier Power in the Pharmaceuticals Market in Canada, 2007
- Figure 19: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada, 2007
- Figure 20: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada, 2007
- Figure 21: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada, 2007
- Figure 22: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 23: United States Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 24: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 25: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 26: United States Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 27: Forces Driving Competition in the Pharmaceuticals Market in the US, 2007
- Figure 28: Drivers of Buyer Power in the Pharmaceuticals Market in the US, 2007
- Figure 29: Drivers of Supplier Power in the Pharmaceuticals Market in the US, 2007
- Figure 30: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the US, 2007
- Figure 31: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the US, 2007
- Figure 32: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the US, 2007
- Figure 33: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 34: China Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 35: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 36: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 37: China Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 38: Forces Driving Competition in the Pharmaceuticals Market in China, 2007
- Figure 39: Drivers of Buyer Power in the Pharmaceuticals Market in China, 2007
- Figure 40: Drivers of Supplier Power in the Pharmaceuticals Market in China, 2007
- Figure 41: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China, 2007
- Figure 42: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China, 2007
- Figure 43: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China, 2007
- Figure 44: hina Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 45: Japan Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 46: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 47: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 48: Japan Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 49: Forces Driving Competition in the Pharmaceuticals Market in Japan, 2007
- Figure 50: Drivers of Buyer Power in the Pharmaceuticals Market in Japan, 2007
- Figure 51: Drivers of Supplier Power in the Pharmaceuticals Market in Japan, 2007
- Figure 52: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan, 2007
- Figure 53: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan, 2007
- Figure 54: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan, 2007
- Figure 55: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 56: Belgium Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 57: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 58: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 59: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 60: Forces Driving Competition in the Pharmaceuticals Market in Belgium, 2007
- Figure 61: Drivers of Buyer Power in the Pharmaceuticals Market in Belgium, 2007
- Figure 62: Drivers of Supplier Power in the Pharmaceuticals Market in Belgium, 2007
- Figure 63: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Belgium, 2007
- Figure 64: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Belgium, 2007
- Figure 65: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Belgium, 2007
- Figure 66: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 67: France Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 68: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 69: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 70: France Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 71: Forces Driving Competition in the Pharmaceuticals Market in France, 2007
- Figure 72: Drivers of Buyer Power in the Pharmaceuticals Market in France, 2007
- Figure 73: Drivers of Supplier Power in the Pharmaceuticals Market in France, 2007
- Figure 74: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in France, 2007
- Figure 75: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in France, 2007
- Figure 76: Drivers of Degree of Rivalry in the Pharmaceuticals Market in France, 2007
- Figure 77: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 78: Germany Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 79: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 80: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 81: Germany Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 82: Forces Driving Competition in the Pharmaceuticals Market in Germany, 2007
- Figure 83: Drivers of Buyer Power in the Pharmaceuticals Market in Germany, 2007
- Figure 84: Drivers of Supplier Power in the Pharmaceuticals Market in Germany, 2007
- Figure 85: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Germany, 2007
- Figure 86: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Germany, 2007
- Figure 87: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Germany, 2007
- Figure 88: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 89: Italy Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 90: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 91: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 92: Italy Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 93: Forces Driving Competition in the Pharmaceuticals Market in Italy, 2007
- Figure 94: Drivers of Buyer Power in the Pharmaceuticals Market in Italy, 2007
- Figure 95: Drivers of Supplier Power in the Pharmaceuticals Market in Italy, 2007
- Figure 96: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Italy, 2007
- Figure 97: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Italy, 2007
- Figure 98: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Italy, 2007
- Figure 99: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 100: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 101: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 102: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 103: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 104: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 105: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 106: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 107: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 108: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 109: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands, 2007
- Figure 110: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 111: Spain Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 112: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 113: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 114: Spain Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 115: Forces Driving Competition in the Pharmaceuticals Market in Spain, 2007
- Figure 116: Drivers of Buyer Power in the Pharmaceuticals Market in Spain, 2007
- Figure 117: Drivers of Supplier Power in the Pharmaceuticals Market in Spain, 2007
- Figure 118: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Spain, 2007
- Figure 119: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Spain, 2007
- Figure 120: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Spain, 2007
- Figure 121: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 122: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 123: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 124: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 125: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 126: Forces Driving Competition in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 127: Drivers of Buyer Power in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 128: Drivers of Supplier Power in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 129: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 130: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 131: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the United Kingdom, 2007
- Figure 132: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 133: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 134: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 135: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 136: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 137: Forces Driving Competition in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 138: Drivers of Buyer Power in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 139: Drivers of Supplier Power in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 140: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 141: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 142: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Asia-Pacific, 2007
- Figure 143: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 144: Europe Pharmaceuticals Market Value: $ million, 2003-2007
- Figure 145: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
- Figure 146: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
- Figure 147: Europe Pharmaceuticals Market Share: % Share, by Value, 2007
- Figure 148: Forces Driving Competition in the Pharmaceuticals Market in Europe, 2007
- Figure 149: Drivers of Buyer Power in the Pharmaceuticals Market in Europe, 2007
- Figure 150: Drivers of Supplier Power in the Pharmaceuticals Market in Europe, 2007
- Figure 151: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe, 2007
- Figure 152: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe, 2007
- Figure 153: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe, 2007
- Figure 154: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012
- Figure 155: Revenues & Profitability: Pfizer Inc
- Figure 156: Revenues & Profitability: GlaxoSmithKline Plc
- Figure 157: Revenues & Profitability: Johnson & Johnson
- Figure 158: Revenues & Profitability: Merck & Co., Inc